NVCR – novocure limited - ordinary shares (US:NASDAQ)

News

Novocure names Frank Leonard as CEO [Seeking Alpha]
Novocure Appoints Company President Frank Leonard as Chief Executive Officer
Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference
Novocure to Participate in 2025 Jefferies Global Healthcare Conference
NovoCure (NASDAQ:NVCR) had its price target raised by analysts at HC Wainwright from $38.00 to $42.00. They now have a "buy" rating on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com